BIO Key Company Top Insiders

BKYI Stock  USD 0.83  0.01  1.22%   
BIO Key employs about 41 people. The company is managed by 9 executives with a total tenure of roughly 60 years, averaging almost 6.0 years of service per executive, having 4.56 employees per reported executive. Assessment of BIO Key's management performance can provide insight into the firm performance.
Kwok Wong  Chairman
MD ViceChairman
Michael DePasquale  Chairman
Chairman, CEO and Pres
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

BIO Key Management Team Effectiveness

The company has return on total asset (ROA) of (0.3373) % which means that it has lost $0.3373 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1229) %, meaning that it created substantial loss on money invested by shareholders. BIO Key's management efficiency ratios could be used to measure how well BIO Key manages its routine affairs as well as how well it operates its assets and liabilities.

BIO Key Workforce Comparison

BIO Key International is number one stock in number of employees category among its peers. The total workforce of Information Technology industry is currently estimated at about 468. BIO Key holds roughly 41.0 in number of employees claiming about 9% of equities under Information Technology industry.
The company has Profit Margin (PM) of (0.71) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.4) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.4.

BIO Key Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BIO Key insiders, such as employees or executives, is commonly permitted as long as it does not rely on BIO Key's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, BIO Key insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

BIO Key Notable Stakeholders

A BIO Key stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BIO Key often face trade-offs trying to please all of them. BIO Key's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BIO Key's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kwok WongMD ViceChairmanProfile
Michael DePasqualeChairman, CEO and PresProfile
Mark CochranPresident PortalGuardProfile
Cecilia WelchChief OfficerProfile
Akintunde JejeManaging AfricaProfile
Alex RochaManaging EMEAProfile
Mira LaCousChief OfficerProfile
Frederick CorsentinoChief Revenue OfficerProfile
James SullivanSenior OfficerProfile

About BIO Key Management Performance

The success or failure of an entity such as BIO Key International often depends on how effective the management is. BIO Key management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BIO management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BIO management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey. Bio-Key Intl operates under Security Protection Services classification in the United States and is traded on NASDAQ Exchange. It employs 51 people.

BIO Key Workforce Analysis

Traditionally, organizations such as BIO Key use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BIO Key within its industry.

BIO Key Manpower Efficiency

Return on BIO Key Manpower

Revenue Per Employee169K
Revenue Per Executive770K
Net Loss Per Employee104.9K
Net Loss Per Executive477.9K

Complementary Tools for BIO Stock analysis

When running BIO Key's price analysis, check to measure BIO Key's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO Key is operating at the current time. Most of BIO Key's value examination focuses on studying past and present price action to predict the probability of BIO Key's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIO Key's price. Additionally, you may evaluate how the addition of BIO Key to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio